Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

CARPOOL Radial Access as Good as Femoral in PAD Procedures

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

March 16, 2026

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

News Conference News CRT 2026

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

March 11, 2026

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

News Conference News CRT 2026

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

Michael O'Riordan

March 11, 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

March 09, 2026

CRT 2026: What to Expect in Washington, DC

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

March 04, 2026

STEMI Revascularization Times All Over the Map: GWTG Registry

News Conference News CRT 2025

STEMI Revascularization Times All Over the Map: GWTG Registry

March 14, 2025

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

March 20, 2024

Small Study Highlights the Serious Nature of Coronary Stent Infections

News Conference News CRT 2023

Small Study Highlights the Serious Nature of Coronary Stent Infections

Yael L. Maxwell

March 04, 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

March 02, 2022

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

News Conference News CRT 2021

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

March 16, 2021

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

News Conference News CRT 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

March 03, 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

CABG vs PCI in Left Main Disease: The Debate Continues

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

News Conference News CRT 2019

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

Yael L. Maxwell

March 07, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.